pubrio
Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

Public
medicalgorithmics.com
ソフトウェア開発200+ employeesFounded 2005🇵🇱 ポーランド

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

設立年
2005
従業員数
200+
業種
ソフトウェア開発
企業タイプ
Public Company
本社
🇵🇱Warszawa, - (+2)
専門分野
IT&サービス医療機器ソフトウェア開発医療人工知能

拡大インテリジェンス

NEW · Pubrio 限定

Medicalgorithmics S.A. の市場拡大を追跡しています

グローバル展開

ライブ
ステージ
検討中投資中参入中稼働中

アクティビティパルス

新しいマーケティング・PRのアクティビティ — 34 件の新規シグナルが出現しました。

過去 90 日間
採用
0
アクティビティなし
マーケティング・PR
34新規
広告
プロダクト・技術
0
アクティビティなし
+2さらにカテゴリロック中
5件中3件を表示
知っておきたい情報

Medicalgorithmics S.A. に関するよくある質問

Medicalgorithmics S.A. の事業、市場、成長シグナルに関する簡潔な回答。

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

今日から旅を始めましょう

まずはプラットフォームでも、まずは会話からでも

Pubrio を自分で使うことも、リサーチ・リード獲得・データ連携を私たちに任せることもできます。

チームに相談
Start Journey Image
pubrio

Pubrio は 50 以上のローカルソースからビジネス・人物・インテントデータを統合し、AI と収益チームに市場全体の可視性を提供します。

© 2026 Pubrio. 無断転載を禁じます。